Christine Ocampo serves as Executive at AVANIR PHARMACEUTICALS, where they oversee executive responsibilities. Since joining the company, Christine Ocampo has executed 58 insider transactions totaling $2.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 11, 2010 involved exercising options for 12,000 shares valued at $10.6K.
Christine Ocampo currently holds 77,179 shares of AVANIR PHARMACEUTICALS (AVNR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christine Ocampo has been a net seller of AVNR stock. They have purchased $113.0K and sold $2.5M worth of shares.
Christine Ocampo's most recent insider trade was on Aug 11, 2010, when they sold 12,000 shares at $0.88 per share.
Get notified when new Form 4 filings are submitted
| $3.11 |
| Discretionary |
| Mar 16, 2010 | AVNR | $208 | Sale | 100 | $2.08 | Discretionary |
| Mar 16, 2010 | AVNR | $22.9K | Sale | 11,000 | $2.08 | Discretionary |
| Mar 16, 2010 | AVNR | $416 | Sale | 200 | $2.08 | Discretionary |
| Mar 16, 2010 | AVNR | $8.8K | Sale | 4,218 | $2.08 | Discretionary |
| Feb 24, 2009 | AVNR | $420 | Purchase | 1,000 | $0.42 | Discretionary |
| Feb 24, 2009 | AVNR | $4.8K | Purchase | 10,900 | $0.44 | Discretionary |